# FDA Inspection 1289844 - Novartis Pharma Schweizerhalle Ag - March 27, 2025

Source: https://www.globalkeysolutions.net/records/fda_inspections/novartis-pharma-schweizerhalle-ag/dda3096b-3761-4342-99f4-73046080c43f
Source feed: FDA_Inspections

> FDA Inspection 1289844 for Novartis Pharma Schweizerhalle Ag on March 27, 2025. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1289844
- Company Name: Novartis Pharma Schweizerhalle Ag
- Inspection Date: 2025-03-27
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1289844 - 2025-03-27](https://www.globalkeysolutions.net/records/fda_inspections/novartis-pharma-schweizerhalle-ag/426d52b5-dc1f-4704-913c-80edd7ad9efb)
- [FDA Inspection 1180967 - 2022-08-25](https://www.globalkeysolutions.net/records/fda_inspections/novartis-pharma-schweizerhalle-ag/7e783f84-0c3b-46b3-98e9-9917cb43c801)
- [FDA Inspection 1018347 - 2017-06-23](https://www.globalkeysolutions.net/records/fda_inspections/novartis-pharma-schweizerhalle-ag/2cdde624-22f5-4870-9fa8-c81a20271c4f)
- [FDA Inspection 938183 - 2015-07-14](https://www.globalkeysolutions.net/records/fda_inspections/novartis-pharma-schweizerhalle-ag/32ece39a-6d27-4f5e-9dd8-69bdc335039a)
- [FDA Inspection 810431 - 2012-09-25](https://www.globalkeysolutions.net/records/fda_inspections/novartis-pharma-schweizerhalle-ag/642fc600-b448-4c0b-b788-ab76a8464b59)

Company: https://www.globalkeysolutions.net/companies/novartis-pharma-schweizerhalle-ag/98c70c71-2e4d-4ca3-9db3-d7582815b731

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c